Transhiatal versus Left Transthoracic Esophagectomy for Gastroesophageal Junction Cancer; The Impact of Surgical Approach on Postoperative Complications
- PMID: 31380007
- PMCID: PMC6663288
- DOI: 10.15171/mejdd.2018.135
Transhiatal versus Left Transthoracic Esophagectomy for Gastroesophageal Junction Cancer; The Impact of Surgical Approach on Postoperative Complications
Abstract
BACKGROUND Esophagectomy is the mainstay of treatment for esophageal cancer. Although different surgical approaches have been described, choosing the most appropriate technique is still on debate. We compared the complications of transhiatal esophagectomy (THE) versus left transthoracic esophagectomy (LTE) among a group of Iranian patients with gastroesophageal junction cancer. METHODS This was a retrospective study between 2011 and 2013 on 40 patients with gastroesophageal cancer. 23 patients underwent THE and the others underwent LTE. 30-day postoperative mortality, complications, duration of hospital stay, and number of dissected lymph nodes were studied. RESULTS 37.5% of the patients had squamous cell carcinoma. No mortality was seen. Totally, 10 patients suffered from complications. Cardiac and pulmonary complications occurred in eight and six patients, respectively. No patients suffered from vocal cord injuries and anastomotic leakage. The mean duration of postoperative hospital stay was 11.82 ± 3.8 days, and the mean number of dissected lymph nodes was 8.2 ± 3.9. No significant difference was seen between the two groups (p > 0.05). CONCLUSION Choosing between the approaches for resection of gastroesophageal cancer may not impact the complications and mortality rates. We propose that LTE approach could be used safely in comparison with THE, and that selecting between THE and LTE may be based on the surgeon's preference and experience.
Keywords: Complication; Esophagectomy; Gastroesophageal junction cancer; Iran; Left transthoracic esophagectomy; Transhiatal esophagectomy.
Conflict of interest statement
CONFLICT OF INTEREST The authors declare no conflict of interest related to this work.
Similar articles
-
Efficacy comparison of transcervical video-assisted mediastinoscopic lymphadenectomy combined with left transthoracic esophagectomy versus right transthoracic esophagectomy for esophageal cancer treatment.World J Surg Oncol. 2018 Feb 9;16(1):25. doi: 10.1186/s12957-017-1268-3. World J Surg Oncol. 2018. PMID: 29426329 Free PMC article.
-
Transthoracic Versus Transhiatal Esophagectomy for Esophageal Cancer: A Nationwide Propensity Score-Matched Cohort Analysis.Ann Surg Oncol. 2021 Jan;28(1):175-183. doi: 10.1245/s10434-020-08760-8. Epub 2020 Jun 30. Ann Surg Oncol. 2021. PMID: 32607607 Free PMC article.
-
Hybrid thoracoscopic esophagectomy for cancer - retrospective analysis and comparison with transhiatal resection.Rozhl Chir. 2018 Spring;97(7):320-327. Rozhl Chir. 2018. PMID: 30442013 English.
-
Transthoracic versus transhiatal esophagectomy for distal esophageal cancer: which is superior?Interact Cardiovasc Thorac Surg. 2011 Feb;12(2):265-9. doi: 10.1510/icvts.2010.252148. Epub 2010 Nov 3. Interact Cardiovasc Thorac Surg. 2011. PMID: 21051381 Review.
-
[Differentiated surgical approach for adenocarcinoma of the gastroesophageal junction].Chirurg. 2017 Dec;88(12):1010-1016. doi: 10.1007/s00104-017-0544-7. Chirurg. 2017. PMID: 29098306 Review. German.
Cited by
-
TRANSHIATAL ESOPHAGECTOMY IN SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS: WHAT ARE THE BEST INDICATIONS?Arq Bras Cir Dig. 2021 Mar 22;33(4):e1567. doi: 10.1590/0102-672020200004e1567. eCollection 2021. Arq Bras Cir Dig. 2021. PMID: 33759957 Free PMC article.
-
Transthoracic, thoracoabdominal, and transabdominal surgical approaches for gastric cardia adenocarcinomas: a survival evaluation based on a cohort of 7103 patients.World J Surg Oncol. 2022 Jun 28;20(1):217. doi: 10.1186/s12957-022-02680-5. World J Surg Oncol. 2022. PMID: 35764996 Free PMC article.
References
-
- Cao X, Xiao J, Wang S, Wu B, Huang Z, Huang S. et al. The potential function of transhiatal esophagectomy in the treatment of esophageal carcinoma. Chin Ger J Clin Oncol. 2008;7:31–4. doi: 10.1007/s10330-007-0151-z. - DOI
LinkOut - more resources
Full Text Sources